Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL CURRENT ASSETS
Total Current Assets PRPH - ProPhase Labs, Inc.
47.6 M
LAST VALUE
-11.91%
2 YEAR CAGR
21.14%
5 YEAR CAGR
15.48%
10 YEAR CAGR